Enoxaparin
Lovenox
Low Molecular Weight Heparin
NADAC/unit
$6.7750
No Shortage
Tier 1: 140.1%
9 Manufacturers
59 ANDAs
Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery....
vs. brand Lovenox: Generic saves up to 32% per unit
Market Intelligence
2025-09-03 Class II Recall: Cardinal Health Inc.
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
AMPHASTAR PHARMACEUTICAL INCAMPHASTAR PHARMACEUTICALS INCBE PHARMACEUTICALS AGEMERGE BIOSCIENCE PTE LTDGLAND PHARMA LTDHEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTDSANDOZ INCSANOFI AVENTIS US LLCSHENZHEN TECHDOW PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.